Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Madrigal Pharmaceuticals Inc (MDGL)
Madrigal Pharmaceuticals Inc (MDGL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,256,445
  • Shares Outstanding, K 18,138
  • Annual Sales, $ 0 K
  • Annual Income, $ -295,350 K
  • 60-Month Beta -0.55
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 20.10
Trade MDGL with:

Options Overview Details

View History
  • Implied Volatility 0.00% ( unch)
  • Historical Volatility 56.45%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 347.02% on 12/15/22
  • IV Low 0.00% on 03/27/23
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 1,244
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 28,339
  • Open Int (30-Day) 23,124

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/23
See More
  • Average Estimate -4.81
  • Number of Estimates 7
  • High Estimate -3.79
  • Low Estimate -5.46
  • Prior Year -3.36
  • Growth Rate Est. (year over year) -43.15%

Price Performance

See More
Period Period Low Period High Performance
1-Month
222.87 +5.29%
on 03/23/23
280.78 -16.42%
on 03/01/23
-41.53 (-15.04%)
since 02/24/23
3-Month
222.87 +5.29%
on 03/23/23
313.93 -25.25%
on 01/24/23
-38.89 (-14.22%)
since 12/23/22
52-Week
57.15 +310.60%
on 05/09/22
315.45 -25.61%
on 12/22/22
+138.71 (+144.55%)
since 03/24/22

Most Recent Stories

More News
Is Viking Therapeutics a Smart Buy on the Dip?

The stock recently fell around 25% for reasons that had nothing to do with its lead program.

NVO : 153.57 (+0.54%)
VKTX : 8.95 (+1.13%)
ALT : 4.43 (+2.55%)
MDGL : 234.67 (+1.17%)
89bio (ETNB) Up 25% on Upbeat Data From Mid-Stage NASH Study

Data from a phase IIb study showed that treatment with 89bio's (ETNB) lead candidate improved fibrosis improved fibrosis at 3.5 times the rate of the placebo without worsening NASH.

ATRA : 2.88 (+0.35%)
MDGL : 234.67 (+1.17%)
RCEL : 12.84 (-0.23%)
ETNB : 16.08 (-1.17%)
Want Diversified Upside in Biotechnology? Check out LABU

Watch the Direxion Daily S&P 500 Biotech Bull 3X Shares (NYSEARCA: LABU) if you want a speculative play in the biotechnology industry with amplified volatility.

XBI : 75.08 (+1.20%)
CYTK : 33.36 (-0.80%)
LABU : 4.74 (+3.72%)
MDGL : 234.67 (+1.17%)
ARWR : 24.29 (+2.58%)
LABD : 21.62 (-3.87%)
Intercept (ICPT) Stock Down on FDA Committee Update on NDA

Intercept (ICPT) declines on news of a GIDAC meeting to discuss the NDA for the OCA for NASH in May.

ICPT : 13.46 (-1.68%)
VKTX : 8.95 (+1.13%)
MDGL : 234.67 (+1.17%)
Heres Why Intercept (ICPT) Stock is Up 28.7% in 3 Months

Intercept (ICPT) gains 28.7% in the past 3 months on NDA's acceptance for NASH treatment and Ocaliva's performance.

ICPT : 13.46 (-1.68%)
VKTX : 8.95 (+1.13%)
MDGL : 234.67 (+1.17%)
1 Incredible Growth Stock That Could Turn $200,000 Into $1 Million by 2030

This clinical-stage biopharma stock could harbor one of the best-selling drugs of all time.

MDGL : 234.67 (+1.17%)
3 Incredible Growth Stocks to Buy if the Market Dips

These top growth stocks sport premium valuations for a very good reason.

LLY : 332.46 (-1.09%)
MDGL : 234.67 (+1.17%)
VRTX : 314.39 (+3.16%)
2 Surging Healthcare Stocks That Are Still Worth Buying

These two NASH drugmakers have a lot of room to run.

MDGL : 234.67 (+1.17%)
VKTX : 8.95 (+1.13%)
Madrigal: Q4 Earnings Snapshot

Madrigal: Q4 Earnings Snapshot

MDGL : 234.67 (+1.17%)
This "Golden" Technical Indicator is Triggering Across the Market

A Golden Cross is a simple, yet effective technical indicator. Andrew Rocco explains how to use it and relates it back to the current market.

BIIB : 270.22 (+0.07%)
NVDA : 269.16 (+0.51%)
QQQ : 311.93 (+0.33%)
SPY : 395.75 (unch)
SMH : 255.18 (+0.22%)
XBI : 75.08 (+1.20%)
MDGL : 234.67 (+1.17%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Madrigal Pharmaceuticals, Inc. is engaged in developing small-molecule drugs addressing cardiovascular and metabolic diseases. Its products pipeline include MGL-3196, an orally administered liver-directed thyroid hormone receptor-' agonist that is used for the treatment of NASH, dyslipidemia/hypercholesterolemia...

See More

Key Turning Points

3rd Resistance Point 247.88
2nd Resistance Point 241.28
1st Resistance Point 237.97
Last Price 234.67
1st Support Level 228.06
2nd Support Level 221.46
3rd Support Level 218.15

See More

52-Week High 315.45
Last Price 234.67
Fibonacci 61.8% 216.78
Fibonacci 50% 186.30
Fibonacci 38.2% 155.82
52-Week Low 57.15

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar